Skip to main content
Have a personal or library account? Click to login
NCR1 and NCR3 Expression and Genetic Polymorphism are Associated with CMV Infection after Allogeneic Haematopoietic Stem Cell Transplantation Cover

References

  1. Almishri W, Santodomingo-Garzon T, Le T et al. (2016) TNFα augments cytokine-induced NK cell IFNγ production through TNFR2. J Innate Immun 8:617–629. https://doi.org/10.1159/000448077
  2. Alvarez M, Pierini A, Baker J et al. (2016) Impact of donor T cells on NK cell development after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. Abstracts from the 2016 BMT Tandem Meetings. 3(22):S149–S150. https://doi.org/10.1016/j.bbmt.2015.11.498
  3. Andoniou CE, van Dommelen SL, Voigt V et al. (2005) Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nat Immunol 6:1011–1019. https://doi.org/10.1038/ni1244
  4. Andrews DM, Andoniou CE, Granucci F et al. (2001) Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nat Immunol 2:1077–1084. https://doi.org/10.1038/ni724
  5. Arnon TI, Lev M, Katz G et al. (2001) Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur J Immunol 31:2680–2689. https://doi.org/10.1002/1521-4141(200109)31:9<;2680:aidimmu2680>3.0.co;2-a
  6. Arnon TI, Markel G, Mandelboim O (2006) Tumor and viral recognition by natural killer cells receptors. Semin Cancer Biol 16: 348–358. https://doi.org/10.1016/j.semcancer.2006.07.005
  7. Barrow AD, Martin CJ, Colonna M (2019) The natural cytotoxicity receptors in health and disease. Front Immunol 10:909. https://doi.org/10.3389/fimmu.2019.00909
  8. Berhani O, Glasner A, Kahlon S et al. (2019) Human anti-NKp46 antibody for studies of NKp46-dependent NK cell function and its applications for type 1 diabetes and cancer research. Eur J Immunol 49:228–241. https://doi.org/10.1002/eji.201847611
  9. Bogunia-Kubik K, Łacina P (2021) Non-KIR NK cell receptors: Role in transplantation of allogeneic haematopoietic stem cells. Int J Immunogenet 48:157–171. https://doi.org/10.1111/iji.12523
  10. Borst K, Flindt S, Blank P et al. (2020) Selective reconstitution of IFN γ gene function in Ncr1+ NK cells is sufficient to control systemic vaccinia virus infection. PLoS Pathog 16:e1008279. https://doi.org/10.1371/journal.ppat.1008279
  11. Campbell KS, Yusa S, Kikuchi-Maki A et al. (2004) NKp44 triggers nk cell activation through DAP12 association that is not influenced by a putative cytoplasmic inhibitory sequence. J Immunol 172:899–906. https://doi.org/10.4049/jimmunol.172.2.899
  12. Cantoni C, Bottino C, Vitale M et al. (1999) NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J Exp Med 189:787–796. https://doi.org/10.1084/jem.189.5.787
  13. Clausen J, Wolf D, Petzer AL et al. (2007) Impact of natural killer cell dose and donor killer-cell immunoglobulin-like receptor (KIR) genotype on outcome following human leucocyte antigen-identical haematopoietic stem cell transplantation. Clin Exp Immunol 148:520–528. https://doi.org/10.1111/j.1365-2249.2007.03360.x
  14. Costello RT, Sivori S, Marcenaro E et al. (2002) Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia. Blood 99:3661–3667. https://doi.org/10.1182/blood.v99.10.3661
  15. Delahaye NF, Barbier M, Fumoux F et al. (2007) Association analyses of NCR3 polymorphisms with P. falciparum mild malaria. Microbes Infect 9:160–166. https://doi.org/10.1016/j.micinf.2006.11.002
  16. Falk CS, Mach M, Schendel DJ et al. (2002) NK cell activity during human cytomegalovirus infection is dominated by US2–11-mediated HLA class I down-regulation. J Immunol 169:3257–3266. https://doi.org/10.4049/jimmunol.169.6.3257
  17. Faraci M, Bagnasco F, Leoni M et al. (2018) Evaluation of chimerism dynamics after allogeneic hematopoietic stem cell transplantation in children with nonmalignant diseases. Biol Blood Marrow Transplant 24:1088–1093. https://doi.org/10.1016/j.bbmt.2017.12.801
  18. Fauriat C, Just-Landi S, Mallet F et al. (2007) Deficient expression of NCR in NK cells from acute myeloid leukemia. Blood 109:323–330. https://doi.org/10.1182/blood-2005-08-027979
  19. Gail LM, Schell KJ, Łacina P et al. (2023) Complex interactions of cellular players in chronic graft-versus-host disease. Front Immunol 14:1199422. https://doi.org/10.3389/fimmu.2023.1199422
  20. Gazit R, Gruda R, Elboim M et al. (2006) Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat Immunol 7:517–523. https://doi.org/10.1038/ni1322
  21. Ghadially H, Ohana M, Elboim M et al. (2014) NK cell receptor NKp46 regulates graft-versus-host disease. Cell Rep 7: 1809–1814. https://doi.org/10.1016/j.celrep.2014.05.011
  22. Guidotti S, Bassi S, Rossi A et al. (2022) Mixed T cell CHIMERISM in bone marrow at day+30 after allogeneic stem cell transplantation. Eur J Haematol 109:83–89. https://doi.org/10.1111/ejh.13772
  23. Gumá M, Angulo A, Vilches C et al. (2004) Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 104:3664–3671. https://doi.org/10.1182/blood-2004-05-2058
  24. Hudspeth K, Silva-Santos B, Mavilio D (2013) Natural cytotoxicity receptors. Front Immunol 4:69. https://doi.org/10.3389/fimmu.2013.00069
  25. Kärre K, Ljunggren HG, Piontek G et al. (1986) Selective rejection of H-2-deficient lymphoma variants. Nature 319:675–678. https://doi.org/10.1038/319675a0
  26. Koka R, Burkett P, Chien M et al. (2004) Cutting edge: Murine dendritic cells require IL-15Rα to prime NK cells. J Immunol 173:3594–3598. https://doi.org/10.4049/jimmunol.173.6.3594
  27. Kruse PH, Matta J, Ugolini S et al. (2014) Natural cytotoxicity receptors and their ligands. Immunol Cell Biol 92:221–229. https://doi.org/10.1038/icb.2013.98
  28. Liu L, Cui Q, Li M et al. (2022) Case report: Rare persistent complete donor chimerism and GVHD following micro-transplantation from HLA haplotype homozygous donors. Front Immunol 13:1005364. https://doi.org/10.3389/fimmu.2022.1005364
  29. Lucas M, Schachterle W, Oberle K et al. (2007) Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 6:503–517. https://doi.org/10.1016/j.immuni.2007.03.006
  30. Luna JI, Grossenbacher SK, Murphy WJ et al. (2017) Targeting cancer stem cells with natural killer cell immunotherapy. Expert Opin Biol Ther 17:313–324. https://doi.org/10.1080/14712598.2017.1271874
  31. Magri G, Muntasell A, Romo N et al. (2011) NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies. Blood 117:848–856. https://doi.org/10.1182/blood-2010-08-301374
  32. Mandelboim O, Lieberman N, Lev M et al. (2001) Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409:1055–1060. https://doi.org/10.1038/35059110
  33. McNab F, Mayer-Barber K, Sher A et al. (2015) Type I interferons in infectious disease. Nat Rev Immunol 15:87–103. https://doi.org/10.1038/nri3787
  34. Minculescu L, Marquart HV, Friis LS et al. (2016) Early natural killer cell reconstitution predicts overall survival in T cell-replete allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 22:2187–2193. https://doi.org/10.1016/j.bbmt.2016.09.006
  35. Moretta A, Bottino C, Vitale M et al. (2001) Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 19:197–223. https://doi.org/10.1146/annurev.immunol.19.1.197
  36. Ogonek J, Kralj Juric M, Ghimire S et al. (2008) Immune reconstitution after allogeneic hematopoietic stem cell transplantation. Front Immunol 7:507. https://doi.org/10.3389/fimmu.2016.00507
  37. Palmer JM, Rajasekaran K, Thakar MS et al. (2013) Clinical relevance of natural killer cells following hematopoietic stem cell transplantation. J Cancer 4:25–35. https://doi.org/10.7150/jca.5049
  38. Parodi M, Favoreel H, Candiano G et al. (2019) NKp44-NKp44 ligand interactions in the regulation of natural killer cells and other innate lymphoid cells in humans. Front Immunol 10:719. https://doi.org/10.3389/fimmu.2019.00719
  39. Pinheiro PF, Justino GC, Marques MM (2020) NKp30 - A prospective target for new cancer immunotherapy strategies. Br J Pharmacol 177:4563–4580. https://doi.org/10.1111/bph.15222
  40. Raulet DH (2006) Missing self recognition and self tolerance of natural killer (NK) cells. Semin Immunol 18:145–150. https://doi.org/10.1016/j.smim.2006.03.003
  41. Sherry ST, Ward M, Sirotkin K (1999) dbSNP—database for single nucleotide polymorphisms and other classes of minor genetic variation. Genome Res 9:677–679. https://doi.org/10.1101/gr.9.8.677
  42. Siemaszko J, Łacina P, Szymczak D et al. (2023) Significance of HLA-E and its two NKG2 receptors in development of complications after allogeneic transplantation of hematopoietic stem cells. Front Immunol 14:1227897. https://doi.org/10.3389/fimmu.2023.1227897
  43. Siemaszko J, Łacina P, Szymczak D et al. (2024) Soluble MICA concentrations and genetic variability of MICA and its NKG2D receptor as factors affecting Graft-versus-Host Disease development after allogeneic haematopoietic stem cell transplantation. Hum Immunol 85:111147. https://doi.org/10.1016/j.humimm.2024.111147
  44. Sivori S, Pende D, Bottino C et al. (1999) The murine homologue of the human NKp46, a triggering receptor involved in the induction of natural cytotoxicity. Eur J Immunol 29:1014–1020. https://doi.org/10.1002/(SICI)1521-4141(199903)
  45. Storek J, Geddes M, Khan F et al. (2008) Reconstitution of the immune system after hematopoietic stem cell transplantation in humans. Semin Immunopathol 30:425–437. https://doi.org/10.1007/s00281-008-0132-5
  46. Vela-Ojeda J, García-Ruiz Esparza MA, Reyes-Maldonado E et al. (2006) Clinical relevance of NK, NKT, and dendritic cell dose in patients receiving G-CSF-mobilized peripheral blood allogeneic stem cell transplantation. Ann Hematol 85:113–120. https://doi.org/10.1007/s00277-005-0037-5
  47. Vitale M, Bottino C, Sivori S et al. (1998) NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J Exp Med 187:2065–2072. https://doi.org/10.1084/jem.187.12.2065
  48. Vitale M, Della Chiesa M, Carlomagno S et al. (2005) NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Blood 106:566–571. https://doi.org/10.1182/blood-2004-10-4035
  49. Xu Z, Taylor JA (2009) SNPinfo: Integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucl Acids Res 37:W600–5. https://doi.org/10.1093/nar/gkp290
Language: English
Submitted on: Jan 7, 2026
Accepted on: Mar 17, 2026
Published on: Jun 25, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2026 Sylwia Biały, Piotr Łacina, Jagoda Siemaszko, Donata Szymczak, Agnieszka Szeremet, Maciej Majcherek, Anna Czyż, Małgorzata Sobczyk-Kruszelnicka, Wojciech Fidyk, Iwona Solarska, Barbara Nasiłowska-Adamska, Patrycja Skowrońska, Maria Bieniaszewska, Agnieszka Tomaszewska, Grzegorz W. Basak, Sebastian Giebel, Tomasz Wróbel, Katarzyna Bogunia-Kubik, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.